Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2025-12-24 @ 5:07 PM
NCT ID: NCT03961750
Eligibility Criteria: Inclusion Criteria: * Older adults - at least 65 years of age or older * Referred to the NHS falls service and identified as 'at risk of a fall' by the NHS falls team - this will be based on the discretion of the referring falls team. NB participants do not need to have experienced a fall to be included. * Community dwelling - participants need to be living independently, this can include a package of care or family support * Be able to ambulate independently with a walking aid (10 meters in a straight line) * have self-reported visual and auditory capacities to follow the exercises * have the capacity to provide a signed informed-consent statement based on the Six-item screener score with 2 or more wrong answers indicating a high risk of reduced capacity (Callahan et al, 2002, Carpenter et al, 2011). Exclusion Criteria: Participants - * living in a Residential or Care Home * unable to follow simple instructions or guidance * who have a medical contraindication for physical activity, participants will be asked to self-declare in line with the Health Commitment Statement (UKACTIVE,2018) * unable to ambulate independently 10 meters with a walking aid * with a severe visual and auditory disabilities * with an unstable cardiovascular disease * with a neurological disorder that could compromise them from exercising * with a lower-extremity fracture in the past year
Healthy Volunteers: False
Sex: ALL
Minimum Age: 65 Years
Study: NCT03961750
Study Brief:
Protocol Section: NCT03961750